ORCHARD THERAPEUTICS PLC Proceeds from Issuance Initial Public Offering
ORCHARD THERAPEUTICS PLC reported Proceeds from Issuance Initial Public Offering of $130.27 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2021-03-02
- ORCHARD THERAPEUTICS PLC proceeds from issuance initial public offering for fiscal 2019 was $130.27M, a 37.87% decline from fiscal 2018.
- ORCHARD THERAPEUTICS PLC proceeds from issuance initial public offering for fiscal 2018 was $209.67M.
| Period end | Proceeds from Issuance Initial Public Offering 12 month | Proceeds from Issuance Initial Public Offering 12 month as first filed |
|---|---|---|
| 2019-12-31 | $130.27M 10-K · filed 2021-03-02 | |
| 2018-12-31 | $209.67M 10-K · filed 2020-02-27 | $205.47M 20-F · filed 2019-03-22 |